Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA)
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference58 articles.
1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015
2. Treatment and 5-year survival in patients with nonmetastatic prostate cancer: the Norwegian experience;Fossa;Urology,2014
3. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013;Heidenreich;Eur Urol,2014
4. The genetics of castration-resistant prostate cancer: what can the germline tell us?;Sharifi;Clin Cancer Res,2008
5. Global histone post-translational modifications and cancer: biomarkers for diagnosis, prognosis and treatment?;Khan;World J Biol Chem,2015
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Establishment of a prognostic risk model for prostate cancer based on Gleason grading and cuprotosis related genes;Journal of Cancer Research and Clinical Oncology;2024-08-01
2. Pan-cancer analysis of CDKN2A alterations identifies a subset of gastric cancer with a cold tumor immune microenvironment;Human Genomics;2024-05-31
3. Epigenomics, Transcriptomics, and Translational Control in Prostate Cancer;Prostate Cancer;2024
4. Epigenetic regulation of androgen dependent and independent prostate cancer;Advances in Cancer Research;2024
5. An immunosuppressive subtype of senescent tumor cells predicted worse immunotherapy response in lung adenocarcinoma;iScience;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3